checkAd

    STRYKER 864952 - eine der besten Medizintechnikaktien (Seite 41)

    eröffnet am 26.07.06 13:50:26 von
    neuester Beitrag 13.02.24 19:17:12 von
    Beiträge: 456
    ID: 1.073.233
    Aufrufe heute: 3
    Gesamt: 61.469
    Aktive User: 0

    Werte aus der Branche Biotechnologie

    WertpapierKursPerf. %
    2,4000+49,07
    1,1600+40,52
    1,3670+25,30
    1,0340+23,54
    6,7100+22,00
    WertpapierKursPerf. %
    2,5000-13,79
    1,3800-20,80
    0,6700-26,58
    2,1300-34,41
    3,1600-38,64

    Beitrag zu dieser Diskussion schreiben

     Durchsuchen
    • 1
    • 41
    • 46

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 26.02.07 13:09:06
      Beitrag Nr. 56 ()
      na, da wirds heute mal wieder etwas rückwärts gehen...den Wachovias war der run auf die Aktie in letzter zeit wohl jetzt genug....klar kann es jetzt mal ne Pause geben in der Kursentwicklung. Wundern würde mich das nicht
      Gruss space

      Symbol: SYK

      [ SYK ] Stryker cut to market perform at Wachovia
      By MarketWatch
      2/26/2007 06:30:08 AM
      Avatar
      schrieb am 15.02.07 16:15:45
      Beitrag Nr. 55 ()
      die Frau hat was drauf!!!
      Gruss space

      Stryker Announces New Corporate Officer Appointment

      PrintE-mailDisable live quotesRSSDigg itDel.icio.us

      Last Update: 8:00 AM ET Feb 15, 2007


      KALAMAZOO, Mich., Feb 15, 2007 /PRNewswire-FirstCall via COMTEX/ -- Stryker Corporation announced that Katherine A. Owen will join the Company in the newly created position of Vice President, Strategy and Investor Relations.
      In this role, Ms. Owen will be responsible for leading Stryker's strategic planning process, overseeing the Business Development function and driving strong alignment between the Company's mid- and long-term strategies and its external business development plans. Additionally, she will have responsibility for day-to-day Investor Relations activities.
      Prior to joining Stryker, Ms. Owen enjoyed a successful career at Merrill Lynch, serving for eight years as their medical technologies Equity Analyst. Before joining Merrill Lynch, Ms. Owen was an analyst in Cowen & Company's medical technologies group for three years. She has also held meaningful roles at both State Street Bank and Chubb Insurance. Ms. Owen holds a Bachelor of Arts degree in Economics from the University of Massachusetts and an MBA from Boston College.
      Stephen P. MacMillan, President and Chief Executive Officer of Stryker Corporation, stated that "Katherine is uniquely qualified for this new role and brings extensive insight and understanding of the medical technologies industry to Stryker. Her in-depth knowledge of the industry and her valued reputation will contribute greatly in both her strategy and investor relations roles. We are very excited to have her join Stryker's executive leadership team at this time, and know she will help lead us in continuing our strong tradition of exceptional growth."
      Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Stryker also provides outpatient physical therapy services in the United States.
      SOURCE Stryker Corporation
      Avatar
      schrieb am 14.02.07 14:15:18
      Beitrag Nr. 54 ()
      Stryker Sponsors Speaking of Women's Health to Bring Osteoarthritis Education to Millions of Women Nationwide
      Sponsorship Will Help Bring Expert Insight and Objective Information to Wide Audience of Women Regarding a Leading Cause of Disability
      PrintE-mailDisable live quotesRSSDigg itDel.icio.us

      Last Update: 8:07 AM ET Feb 14, 2007


      SAN DIEGO, Feb 14, 2007 /PRNewswire-FirstCall via COMTEX/ -- Speaking of Women's Health, a non-profit organization dedicated to educating women to make informed decisions about their health, well-being and personal safety, has added Stryker Corporation, the world's largest orthopaedics manufacturer, to its prestigious list of Health Initiative sponsors, which also includes Lilly(TM), Kimberly-Clark Corporation(TM), Johnson and Johnson(TM), Unilever(TM), Loreal Paris(TM), Merck(TM), Amylin(TM), Maybelline(TM) New York, Wal-Mart(TM), and others. The sponsorship was announced today during the American Academy of Orthopedic Surgeon's annual conference in San Diego, CA.
      Stryker is providing sponsorship to Speaking of Women's Health to develop educational programs surrounding osteoarthritis and the need to maintain good bone and joint health, through its active participation in more than 50 "It's Time to Get Moving" educational conferences this year, reaching millions of women in more than 30 cities nationwide.
      With the number of osteoarthritis sufferers expected to climb to nearly 60 million by 2020 and the disease disproportionately affecting women,(1) the need to educate women about prevention, care and treatment is more pressing now than ever.
      "Speaking of Women's Health represents a natural fit for Stryker," said Yin Becker, Vice President of Healthcare Innovations, Stryker Orthopaedics, "whether it is implants designed with a women's physiology in mind, or working with orthopaedic surgeons and primary care physicians to help them better understand and act on women's health issues, we are continually looking for new ways to help empower women to lead more active, healthier, satisfying lives."
      Dianne Dunkelman, Founder and CEO of the National Speaking of Women's Health Foundation applauded the partnership. "We are committed to developing sponsorships that not only help us keep our conferences affordable and accessible, but also reinforce our mission of helping to educate women about the power of their health, well-being and personal safety," said Dunkelman. "We are thrilled that Stryker has joined our fine family of sponsors as they are an organization that shares and values this commitment."
      About Speaking of Women's Health
      Speaking of Women's Health's(R) mission is to "educate women to make informed decisions about their health, well-being and personal safety." The 501 (c)(3) nonprofit organization educates and empowers women nationwide through more than 50 conferences and events across the country; its health programs, Universal Sisters and Hablando de la Salud de la Mujer; community events and education centers with free health brochures in Wal-Mart stores nationwide; a free quarterly newsletter, a Web site and a television show, "Lifetime's Speaking of Women's Health." More information about Speaking of Women's Health and Speaking of Women's Health conferences can be found by visiting http://www.speakingofwomenshealth.com.
      About Stryker Corporation
      Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Stryker also provides outpatient physical therapy services in the United States. The Company's website address is http://www.stryker.com
      (TM) All other trademarks are trademarks of their respective owners or holders.
      (1) National Institutes of Health
      SOURCE Stryker Corporation
      Greg Maliczyszyn, +1-646-747-7146, or gmaliczyszyn@kwitco.com; or Dean H. Bergy, Vice President and Chief Financial Officer of Stryker Corporation, +1-269-385-2600 http://www.speakingofwomenshealth.com Copyright (C) 2007 PR Newswire. All rights reserved ********************************************************************** As of Saturday, 02-10-2007 23:59, the latest Comtex SmarTrend(SM) Alert, an automated pattern recognition system, indicated an UPTREND on 01-19-2007 for JNJ @ $67.98. As of Saturday, 02-10-2007 23:59, the latest Comtex SmarTrend(SM) Alert, an automated pattern recognition system, indicated an UPTREND on 07-26-2006 for KMB @ $61.41. As of Saturday, 02-10-2007 23:59, the latest Comtex SmarTrend(SM) Alert, an automated pattern recognition system, indicated an UPTREND on 01-24-2007 for MRK @ $46.00. For more information on Comtex SmarTrend® Alert, contact your market data provider or go to www.CSTADirect.com SmarTrend is a registered trademark of Comtex News Network, Inc. Copyright © 2004-2007 Comtex News Network, Inc. All rights reserved.
      Avatar
      schrieb am 08.02.07 15:22:27
      Beitrag Nr. 53 ()
      latest news [AMSG] AmSurg started at sector perform at RBC Capital

      Stryker Imaging Signs Exclusive Five Year Agreement with Swissray International to Sell and Distribute Swissray Digital Radiography Systems

      PrintE-mailDisable live quotesRSSDigg itDel.icio.us

      Last Update: 8:00 AM ET Feb 8, 2007


      ELIZABETH, N.J., Feb 08, 2007 /PRNewswire via COMTEX/ -- Swissray International, Inc., a leading manufacturer in the Direct Digital Radiographic Systems industry, announced today that it has signed a 5-year agreement with the Imaging Division of Stryker Corporation (SYK : Stryker Corporation
      News , chart, profile, more
      Last: 62.40+0.45+0.73%

      8:57am 02/08/2007

      Delayed quote dataAdd to portfolio
      Analyst
      Create alertInsider
      Discuss
      Financials
      Sponsored by:
      SYK62.40, +0.45, +0.7%) , a leader in the worldwide orthopaedic market and one of the world's largest medical device companies. Stryker direct sales force will sell the Swissray DR systems into the U.S. orthopedic private practice market under the Stryker brand name HDDR. Swissray will utilize their U.S. service and support organization for the installation, application training and maintenance of the Stryker High Definition Digital Radiography, HDDR systems. Swissray was chosen by Stryker Imaging as its DR partner because of the high quality and performance of its technology as well as the special orthopedic functionalities such as Automated Positioning, AutoStitching, Off Center Imaging, True Size Imaging, Scoliosis Imaging, Long Leg Imaging and Weight Bearing Studies. Stryker Imaging will sell all 10 different Swissray DR models to provide its customers a tailored solution according to individual needs.
      Terry Ross, Chairman and CEO of Swissray International said: "The Swissray brand is the most recognized name in orthopedic digital imaging. We are very pleased to enter into this agreement with Stryker to offer the industry multiple detector technology solutions that will be fully integrated into the Stryker OfficePACS(R) product line. A one stop solution is now available from Stryker to fulfill all orthopedic imaging needs."
      Avatar
      schrieb am 05.02.07 14:13:48
      Beitrag Nr. 52 ()
      Antwort auf Beitrag Nr.: 27.439.221 von spaceistheplace am 05.02.07 10:55:08ja, und bei BBD heißt es auch: dabei bleiben!
      gruß

      Trading Spotlight

      Anzeige
      Nurexone Biologic
      0,4080EUR -1,92 %
      NurExone Biologic: Das sollten Sie nicht versäumen! mehr zur Aktie »
      Avatar
      schrieb am 05.02.07 10:55:08
      Beitrag Nr. 51 ()
      Antwort auf Beitrag Nr.: 27.437.877 von boccador am 05.02.07 09:34:31Sehr gut, boccador, und Gratulation! Wir kennen uns vom BBD-Thread, gell?
      Gruss und weiter dabei bleiben...
      space
      Avatar
      schrieb am 05.02.07 09:34:31
      Beitrag Nr. 50 ()
      oh doch, interessiert mich auch! habe ne menge dvon und das seit vielen jahren und ich gebe auch kein stück her!
      Avatar
      schrieb am 05.02.07 08:21:23
      Beitrag Nr. 49 ()
      Jou Pontius, Du hast recht! da soll noch einer vestehen können. da wird lieber in irgendwelche kleeene Klitschen investiert, die irgendwann bankrott oder sonst was sind...oder in die Deutsche Telekom, dem deutschen Wachstumsunternehmen par excellance...
      Mensch Leute, warum nicht in so was gehen, wo die Perspektiven auf Jahre hinaus noch stimmen...

      Gruss space
      Avatar
      schrieb am 04.02.07 16:04:38
      Beitrag Nr. 48 ()
      Die Aktie läuft und läuft. Und es interresiert auser space und meiner wenigkeit keine socke.:laugh:
      Ist schon verblüffend




      gruß:cool:
      Avatar
      schrieb am 02.02.07 19:41:10
      Beitrag Nr. 47 ()
      Da hab ich mich verlesen:eek:

      Ja das zeug von denen ist wirklich schon fast unverschämt teuer.
      Momentan expandiert Coach auch sehr stark in Asien. Haben eine starke Marktposition in Japan und ein boomendes China Geschäft.

      Ich denke Europa steht bei denen nicht so weit oben auf der Prioritätsliste. Vermutlich wegen der starken europäischen Luxusmarken. Da ist es in Asien einfacher den Markennamen aufzubauen.

      Ich versteh auch nicht wie man soviel Geld für Handtaschen usw. ausgeben kann. Aber mir ists recht:D

      Man muss sich nur bewusst sein das es bei einer Ergebnisverfehlung auch mal schnell 30 % runter gehen kann. Was mir nicht ganz so gefällt ist das Verhältnis der Marktkapitalisierung zum Umsatz.

      Ich lass die Position einfach mal laufen. Falls es auf 35 fällt kauf ich noch mal zu.

      bis dann ciao
      • 1
      • 41
      • 46
       DurchsuchenBeitrag schreiben


      Investoren beobachten auch:

      WertpapierPerf. %
      -0,65
      +0,41
      -0,60
      +0,01
      -0,28
      +0,39
      -0,18
      +1,01
      +2,03
      +0,91

      Meistdiskutiert

      WertpapierBeiträge
      309
      130
      113
      103
      72
      49
      46
      45
      43
      43
      STRYKER 864952 - eine der besten Medizintechnikaktien